Antibiotics Antibiotics damage the colonic mucus barrier in a microbiota-independent manner (Sep 2024, mice) "Antibiotic use is a risk factor for development of inflammatory bowel diseases (IBDs)"

Michael Harrop

Active member
Joined
Jul 6, 2023
Messages
773
Location
USA
https://www.science.org/doi/10.1126/sciadv.adp4119

Abstract​

Antibiotic use is a risk factor for development of inflammatory bowel diseases (IBDs). IBDs are characterized by a damaged mucus layer, which does not separate the intestinal epithelium from the microbiota.

Here, we hypothesized that antibiotics affect the integrity of the mucus barrier, which allows bacterial penetrance and predisposes to intestinal inflammation.

We found that antibiotic treatment led to breakdown of the colonic mucus barrier and penetration of bacteria into the mucus layer.

Using fecal microbiota transplant, RNA sequencing followed by machine learning, ex vivo mucus secretion measurements, and antibiotic treatment of germ-free mice, we determined that antibiotics induce endoplasmic reticulum stress in the colon that inhibits colonic mucus secretion in a microbiota-independent manner. This antibiotic-induced mucus secretion flaw led to penetration of bacteria into the colonic mucus layer, translocation of microbial antigens into circulation, and exacerbation of ulcerations in a mouse model of IBD.

Thus, antibiotic use might predispose to intestinal inflammation by impeding mucus production.

Microbiota transfer from antibiotic-treated mice to GF mice does not transfer the antibiotic’s effect on the mucus barrier
So it's the antibiotic directly causing the damage.

Next, we wanted to test whether we could reverse the mucus secretion defect caused by vancomycin treatment in vivo. We have previously found that the bile acid tauroursodeoxycholic acid (TUDCA) can increase mucus secretion rates by reducing ER stress in colonic goblet cells (21). As vancomycin treatment induces ER stress in the colon, we attempted to restore proper mucus secretion by alleviating this ER stress using TUDCA. We found that TUDCA treatment reversed the mucus secretion defect caused by vancomycin treatment, restoring a proper mucus barrier (Fig. 4, J and K). Thus, vancomycin treatment inhibits secretion from colonic goblet cells by inducing ER stress.
 
Format correct?
  1. Yes
Last edited:
Back
Top